Treatments

Patients who come to Duke Pediatric Blood and Marrow Transplant (BMT) Program have frequently exhausted all of their other treatment options. They generally have a life expectancy of less than one year without a transplant.

Patients are usually seen within one to two weeks of their referral, despite a lengthy wait list, if it is determined that such speed is necessary.

If transplantation is determined to be the patient’s best option, donors can be identified within a week or two in most cases.

Diseases treated by the Duke Pediatric BMT Program include:

  • Acute leukemias (ALL, AML, ANLL, secondary AML)
  • Chronic leukemias (CML, JCML, JMML)
  • Myelodysplastic syndromes
  • Lymphoma (Hodgkin's and non-Hodgkin's lymphomas)
  • Brain tumors
  • Neuroblastoma and other solid tumors
  • Immunodeficiency syndromes
  • Histiocytic syndromes
  • Platelet disorders
  • Bone marrow failure disorders
  • Inborn errors of metabolism
  • Hemoglobinopathies like sickle cell anemia and thalassemia
  • Refractory autoimmune diseases

Physicians

Physicians offering this service include:

Locations

This service is available at: